Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 6
2012 5
2013 19
2014 12
2015 22
2016 27
2017 14
2018 20
2019 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Core outcome sets and systematic reviews.
Clarke M, Williamson PR. Clarke M, et al. Syst Rev. 2016 Jan 20;5:11. doi: 10.1186/s13643-016-0188-6. Syst Rev. 2016. PMID: 26792080 Free PMC article. Review.
Reflections on the history of systematic reviews.
Clarke M, Chalmers I. Clarke M, et al. BMJ Evid Based Med. 2018 Aug;23(4):121-122. doi: 10.1136/bmjebm-2018-110968. Epub 2018 Jun 19. BMJ Evid Based Med. 2018. PMID: 29921711 No abstract available.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page